Nurix Therapeutics
Price & Volume
Stats
See more52W Range | $8.18-$29.56 |
Market Cap | $874.4M |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $56.4M |
Revenue Growth (YoY) | 11.3% |
Gross Profit (12 Mos) | -$184.8M |
Diluted EPS | -$2.79 |
News
See moreYahoo Finance • 19 days ago
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 22 days ago
Nurix Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate Update
Yahoo Finance • last month
Nurix Therapeutics Announces Multiple Presentations at the American Association for Cancer Research (AACR) 2025 Annual Meeting
Yahoo Finance • 2 months ago
Nurix Therapeutics Appoints Drug Development Expert Roy D. Baynes, MB.Bch., M.Med., Ph.D., to Its Board of Directors
About
CEO | Dr. Arthur T. Sands M.D., Ph.D. |
Address | 1700 Owens Street, San Francisco, CA, United States, 94158 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 286 |
